Advancements and regulations of biomanufacturing cell-based cartilage repair therapies
- PMID: 39393937
- DOI: 10.1016/j.tibtech.2024.09.016
Advancements and regulations of biomanufacturing cell-based cartilage repair therapies
Abstract
Cell-based therapies for cartilage repair, including autologous chondrocyte implantation and allogeneic stem cell treatments, show great promise but face challenges due to high costs and regulatory hurdles. This review summarizes available and investigational products, focusing on allogeneic therapies and the impact of diverse regulatory landscapes on their clinical translation.
Keywords: ACI; MSC; cartilage repair; cell therapy; clinical trial; regulatory.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests None declared by authors.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
